Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Omrix Biopharmaceuticals, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Exercise | $33.7K | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Exercise | $27.2K | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Sell | $69K | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Buy | $14.2K | conv 35 | SEC | |
Omrix Biopharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Omrix Biopharmaceuticals, Inc.Listing unverified | Buy | $14.6K | conv 62 | SEC | |
Omrix Biopharmaceuticals, Inc.Listing unverified | Buy | $10.2K | conv 50First in 12mo | SEC |